FHIR Clinical Guidelines (v1.0.0) (STU1)

This page is part of the Clinical Guidelines (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions

MedicationAdministration-chf-scenario1-lasix-po

Formats: XML, JSON, Turtle

Generated Narrative

Based On: Generated Summary: status: draft; intent: proposal; priority: routine; LASIX PO; instantiatesCanonical: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po

status: on-hold

medication: LASIX PO

subject: Generated Summary: active; Patterson, Jeremy; gender: male; birthDate: 1949-03-17;

effective: Feb 3, 2019 1:00:00 PM

Dosages

-TextRouteDose
*40mgOral Route (qualifier value)40 mg